Amorphous solid dispersion dry powder for pulmonary drug delivery: Advantages and challenges

10. August 2020

Amorphous solid dispersion (ASD) is commonly used in pharmaceutical industry. It has been mainly employed to enhance the oral bioavailability...

Formulating Cannabinoids

4. August 2020

Cannabinoids are challenging APIs to formulate: Being highly lipophilic compounds with low water solubility, cannabinoids need to be solubilized for...

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

3. August 2020

Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous...

Pharmacokinetic Investigation of Synthetic Cannabidiol Oral Formulations in Healthy Volunteers

9. July 2020

Recent advances in the research of medicinal cannabis has placed the non-intoxicating cannabinoid cannabidiol (CBD) at the front of many...

An investigation into the bioavailability of a peroral cannabinoid-Pheroid® formulation

6. July 2020

Cannabidiol (CBD), a phytocannabinoid isolated from the Cannabis sativa plant, has been investigated for its medicinal properties including anti-psychotic, anti-...

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review

2. July 2020

Background and objective: Changes in cannabis legalization regimes in several countries have influenced the diversification of cannabis use. There is...

A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects

2. July 2020

Cannabidiol (CBD), a phytocannabinoid compound of Cannabis sativa, shows limited oral bioavailability due to its lipophilicity and extensive first-pass metabolism....

Nanocomposite Cryogel Carriers from 2-Hydroxyethyl Cellulose Network and Cannabidiol-Loaded Polymeric Micelles for Sustained Topical Delivery

23. May 2020

In this contribution, we report the development of original nanocomposite cryogels for sustained topical delivery of hydrophobic natural active substances...

Convert oily actives (CBD oil) into flowable and compressible powder

19. May 2020

FujiSil™ is a highly porous silica material. It allows you to convert oily actives into flowable and compressible powder. It...

The core benefits of Neusilin® as an excipient – Oil adsorption

17. May 2020

Neusilin® is a Multi-problem solver. It solves common problems associated with tableting by facilitating improved and consistent flow of powder...

CBD